![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, May 16, 2015 10:16:34 AM
Y-90 has been demonstrated to kill tumor cells already with TheraSphere and SIR-Spheres both FDA approved (in 1999 and 2002 respectively). The following things that need to be addressed are
-bio-compatibility of the microsphere (is it toxic to the body? would the matrix react with any other parts of the body to produce side effects?)
-biodegradeability/shelf life (how long is the Y-90 held inside the matrix? 24h? 1week? decades?)
-elimination (how will it be excreted from the body?)
That is probably a really simplified picture (numbers are important), but these are the major areas that ADMD's Radiogel has to tackle. And probably what the FDA is looking for. And it's probably not too difficult to find/make a biocompatible polymer capsule. Look at the stem cell research - they're using PLGA, PLLA, PEG scaffolds in vivo for animal studies already. I'm pretty sure the Radiogel polymer composite is some modification/mixture of these polymers. Or it can be part of the same materials made for the formulation of drugs inside pills. Point being a lot of technology has been developed already and demonstrated to work so there's likely little chance it won't receive FDA approval. It's a matter of whether or not ADMD's scientists and engineers are competent enough to piece it all together. And if somebody is going to drop 5 million dollars for you, it's a good bet that they got it right.
Edit:
This is my evaluation of the technology. I've worked enough in the lab/read enough papers on capsules that it's not particularly difficult to make sufficient matrices. Chitosan, hyaluronic acid, pectin - they've all been used already and are friendly to the body.
Recent RDGL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:28:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM